Table 4 Comparison of the groups on the basis of renal functions and acute phase parameters
|  | All group(n = 12) | AA + FMF(n = 8) | AA + FMF + co-existing diseases(n = 4) | |||
|---|---|---|---|---|---|---|
Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | |
Creatinine (mg/dl) (Female: 0.5–0.9; Male:0.7–1.2) | 1.1 ± 0.9 | 1.0 ± 0.6 | 1.2 ± 1.1 | 1.0 ± 0.7 | 0.9 ± 0.4 | 1.0 ± 0.4 |
GFR (ml/min) (71–151) | 111.7 ± 50.1 | 108.9 ± 54.8 | 118.1 ± 59.4 | 122.1 ± 62.8 | 99.0 ± 25.5 | 82.7 ± 20.4 |
Proteinuria (mg/day) | 6537.6 ± 6526.0 | 4745.5 ± 5462.7 | 7920.1 ± 7576.9 | 5417.9 ± 6585.0 | 3772.6 ± 2628.7 | 3400.6 ± 2149.8 |
CRP (0–5 mg/L) | 18.1 ± 19.5 | 5.8 ± 7.1 | 20.5 ± 23.3 | 4.1 ± 5.2 | 13.3 ± 9.0 | 9.3 ± 10.0 |
Sedimentation (0–20 mm/h) | 48.7 ± 31.0 | 27.8 ± 28.3 | 54.9 ± 34.2 | 24.0 ± 22.4 | 36.3 ± 22.0 | 35.5 ± 40.5 |